[Treatment with intravenous iron and ferritin level].
J
J
Fernández-Gallego
M A
MA
Martín
S
S
Sujan
E
E
Vega
D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D001798:Blood Proteins / Q000187:drug effects; D016022:Case-Control Studies; D002985:Clinical Protocols; D016903:Drug Monitoring; D004920:Erythropoiesis; D004921:Erythropoietin / Q000627:therapeutic use; D005290:Ferric Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000077605:Ferric Oxide, Saccharated; D005293:Ferritins / Q000097:blood*; D005937:Glucaric Acid; D006801:Humans; D007262:Infusions, Intravenous; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D010084:Oxidation-Reduction; D011446:Prospective Studies; D006435:Renal Dialysis / Q000009:adverse effects
D001798:Blood Proteins; D005290:Ferric Compounds; D004921:Erythropoietin; D005293:Ferritins; D000077605:Ferric Oxide, Saccharated; D005937:Glucaric Acid